MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
$4,187,050
EPS
$0.15
Unit: Dollar

Income Statement
2025-12-31
General and administrative costs
488,385
Total operating expenses
488,385
Loss from operations
-488,385
Interest earned on cash and investments held in trust account
4,933,800
Gain on extinguishment of over-allotment option liability
553,748
Provision for credit losses
812,113
Total other income
4,675,435
Net income (loss)
4,187,050
Basic EPS
0.16
Diluted EPS
0.15
Basic Average Shares
13,287,671
Diluted Average Shares
13,287,671
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest earned on cashand investments...$4,933,800 Gain onextinguishment of...$553,748 Total other income$4,675,435 Provision for creditlosses$812,113 Net income (loss)$4,187,050 Loss from operations-$488,385 Total operatingexpenses$488,385 General andadministrative costs$488,385

Drugs Made In America Acquisition II Corp. (DMIIR)

Drugs Made In America Acquisition II Corp. (DMIIR)